End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,989 KRW | -0.15% | +0.20% | +9.41% |
Apr. 05 | Enzychem Lifesciences Corporation announces an Equity Buyback for KRW 10,000 million worth of its shares. | CI |
Apr. 05 | Enzychem Lifesciences Corporation authorizes a Buyback Plan. | CI |
Sales 2022 | 26.64B 19.55M | Sales 2023 | 76.04B 55.81M | Capitalization | 155B 114M |
---|---|---|---|---|---|
Net income 2022 | -25.09B -18.42M | Net income 2023 | -9.33B -6.85M | EV / Sales 2022 | -0.58 x |
Net cash position 2022 | 155B 114M | Net cash position 2023 | 132B 96.66M | EV / Sales 2023 | 0.3 x |
P/E ratio 2022 |
-5.24
x | P/E ratio 2023 |
-16.5
x | Employees | 113 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.03% |
1 day | -0.15% | ||
1 week | +0.20% | ||
Current month | +1.12% | ||
1 month | +13.08% | ||
3 months | +15.77% | ||
6 months | +42.07% | ||
Current year | +9.41% |
Managers | Title | Age | Since |
---|---|---|---|
Gi-Young Sohn
CEO | Chief Executive Officer | 62 | 12-05-31 |
Do-Hyeon Jo
COO | Chief Operating Officer | 49 | 16-10-20 |
Myung-Hwan Kim
BRD | Director/Board Member | 67 | 15-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gi-Young Sohn
CEO | Chief Executive Officer | 62 | 12-05-31 |
Hye-Kyung Kim
BRD | Director/Board Member | 66 | 12-06-30 |
Jae-Yong Lee
BRD | Director/Board Member | 62 | 11-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 1,989 | -0.15% | 424,959 |
24-05-17 | 1,992 | +0.71% | 309,099 |
24-05-16 | 1,978 | +0.30% | 435,549 |
24-05-14 | 1,972 | -0.65% | 518,232 |
End-of-day quote Korea S.E., May 19, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+9.41% | 125M | |
+34.35% | 693B | |
+29.39% | 584B | |
-3.49% | 372B | |
+20.15% | 332B | |
+6.19% | 294B | |
+14.11% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+9.21% | 168B |
- Stock Market
- Equities
- A183490 Stock